BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23040011)

  • 1. Anatomic brain disease in hemodialysis patients: a cross-sectional study.
    Drew DA; Bhadelia R; Tighiouart H; Novak V; Scott TM; Lou KV; Shaffi K; Weiner DE; Sarnak MJ
    Am J Kidney Dis; 2013 Feb; 61(2):271-8. PubMed ID: 23040011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Impairment and Structural Neuroimaging Abnormalities Among Patients with Chronic Kidney Disease.
    Pi HC; Xu YF; Xu R; Yang ZK; Qu Z; Chen YQ; Liu GL; Dong J
    Kidney Blood Press Res; 2016; 41(6):986-996. PubMed ID: 27988515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter damage in maintenance hemodialysis patients: a diffusion tensor imaging study.
    Drew DA; Koo BB; Bhadelia R; Weiner DE; Duncan S; la Garza MM; Gupta A; Tighiouart H; Scott T; Sarnak MJ
    BMC Nephrol; 2017 Jul; 18(1):213. PubMed ID: 28676035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diastolic blood pressure is associated with brain atrophy in hemodialysis patients: A single center case-control study.
    Cohen-Hagai K; Fanadka F; Grumberg T; Topaz G; Nacasch N; Greenberg M; Zitman-Gal T; Benchetrit S
    Ther Apher Dial; 2022 Feb; 26(1):94-102. PubMed ID: 33763913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain white matter microstructure in end-stage kidney disease, cognitive impairment, and circulatory stress.
    Eldehni MT; Odudu A; Mcintyre CW
    Hemodial Int; 2019 Jul; 23(3):356-365. PubMed ID: 30920718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrovascular effects of hemodialysis in chronic kidney disease.
    Prohovnik I; Post J; Uribarri J; Lee H; Sandu O; Langhoff E
    J Cereb Blood Flow Metab; 2007 Nov; 27(11):1861-9. PubMed ID: 17406658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain atrophy in peritoneal dialysis and CKD stages 3-5: a cross-sectional and longitudinal study.
    Tsuruya K; Yoshida H; Kuroki Y; Nagata M; Mizumasa T; Mitsuiki K; Yoshiura T; Hirakawa M; Kanai H; Hori K; Hirakata H; Kitazono T
    Am J Kidney Dis; 2015 Feb; 65(2):312-21. PubMed ID: 25218680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study.
    Vermeer SE; van Dijk EJ; Koudstaal PJ; Oudkerk M; Hofman A; Clarke R; Breteler MM
    Ann Neurol; 2002 Mar; 51(3):285-9. PubMed ID: 11891822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the Relationship between Cerebral Blood Flow and Cognitive Function in Hemodialysis Patients.
    Findlay MD; Dawson J; Dickie DA; Forbes KP; McGlynn D; Quinn T; Mark PB
    J Am Soc Nephrol; 2019 Jan; 30(1):147-158. PubMed ID: 30530658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in peritoneal dialysis patients.
    Kalirao P; Pederson S; Foley RN; Kolste A; Tupper D; Zaun D; Buot V; Murray AM
    Am J Kidney Dis; 2011 Apr; 57(4):612-20. PubMed ID: 21295896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD.
    Martinez-Vea A; Salvadó E; Bardají A; Gutierrez C; Ramos A; García C; Compte T; Peralta C; Broch M; Pastor R; Angelet P; Marcas L; Saurí A; Oliver JA
    Am J Kidney Dis; 2006 Feb; 47(2):241-50. PubMed ID: 16431253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: the Cardiovascular Health Study.
    Luoto R; Manolio T; Meilahn E; Bhadelia R; Furberg C; Cooper L; Kraut M
    J Am Geriatr Soc; 2000 May; 48(5):467-72. PubMed ID: 10811537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study.
    Manolio TA; Kronmal RA; Burke GL; Poirier V; O'Leary DH; Gardin JM; Fried LP; Steinberg EP; Bryan RN
    Stroke; 1994 Feb; 25(2):318-27. PubMed ID: 8303738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible Neuroprotective Effects of l-Carnitine on White-Matter Microstructural Damage and Cognitive Decline in Hemodialysis Patients.
    Ueno Y; Saito A; Nakata J; Kamagata K; Taniguchi D; Motoi Y; Io H; Andica C; Shindo A; Shiina K; Miyamoto N; Yamashiro K; Urabe T; Suzuki Y; Aoki S; Hattori N
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33919810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI of neurologic complications in end-stage renal failure patients on hemodialysis: pictorial review.
    Ağildere AM; Kurt A; Yildirim T; Benli S; Altinörs N
    Eur Radiol; 2001; 11(6):1063-9. PubMed ID: 11419154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular Risk Factors and Findings on Brain MRI of Elderly Adult American Indians: The Strong Heart Study.
    Shibata D; Suchy-Dicey A; Carty CL; Madhyastha T; Ali T; Best L; Grabowski TJ; Longstreth WT; Buchwald D
    Neuroepidemiology; 2019; 52(3-4):173-180. PubMed ID: 30677776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study.
    Appelman AP; Vincken KL; van der Graaf Y; Vlek AL; Witkamp TD; Mali WP; Geerlings MI;
    Cerebrovasc Dis; 2010; 29(1):28-35. PubMed ID: 19893309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kidney disease quality of life cognitive function subscale and cognitive performance in maintenance hemodialysis patients.
    Sorensen EP; Sarnak MJ; Tighiouart H; Scott T; Giang LM; Kirkpatrick B; Lou K; Weiner DE
    Am J Kidney Dis; 2012 Sep; 60(3):417-26. PubMed ID: 22425261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment.
    Fazekas G; Fazekas F; Schmidt R; Kapeller P; Offenbacher H; Krejs GJ
    J Neurol Sci; 1995 Dec; 134(1-2):83-8. PubMed ID: 8747848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral ischemia as a causative mechanism for rapid progression of brain atrophy in chronic hemodialysis patients.
    Yoshimitsu T; Hirakata H; Fujii K; Kanai H; Hirakata E; Higashi H; Kubo M; Tanaka H; Shinozaki M; Katafuchi R; Yokomizo Y; Oh Y; Tomooka S; Fujimi S; Fujishima M
    Clin Nephrol; 2000 Jun; 53(6):445-51. PubMed ID: 10879664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.